Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting

Citius Oncology's LYMPHIR™ exhibit will be located at Booth #265

LYMPHIR launch on track for Q4 2025

CRANFORD, N.J., Nov. 25, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), today announced it will exhibit at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition, taking place December 6–9, 2025, in Orlando, Florida.

Read more at prnewswire.com